Search

everythinglearnresearchcommunity

for

Search:↓

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

A 73-year-old man's grey-white hair turned dark brown after eczema treatment.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

JAK inhibitors and combination therapies show promise for treating severe alopecia areata.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Scalp psoriasis is treated with topical therapies, phototherapy, and systemic medications.

An infant developed excessive hair growth after a bone marrow transplant and cyclosporine treatment.

NFATc1 controls hair stem cell activity, affecting hair growth and could be a target for hair loss treatments.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

No treatment fully prevents hair loss from chemotherapy yet.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Most dermatologic medications are safe during pregnancy and breastfeeding, but some should be avoided due to potential risks.

The document suggests a personalized treatment plan for alopecia areata based on the patient's age and hair loss severity, using a range of therapies ranked by effectiveness and safety.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Early diagnosis and treatment of discoid lupus erythematosus improve outcomes.

Serum from alopecia patients does not stop hair growth in grafted skin on mice.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.